{
    "2021-04-09": [
        [
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：冻干人用狂犬病疫苗(Vero细胞)进入Ⅲ期临床试验",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "冻干人用狂犬病疫苗",
                        "Vero细胞",
                        "Ⅲ期临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "两市百元股数量达134只，医药生物行业占比最高",
                "features": {
                    "keywords": [
                        "百元股",
                        "医药生物",
                        "行业占比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券：医疗板块投资依然聚焦于疫情应对需求、消费医疗和院内诊疗",
                "features": {
                    "keywords": [
                        "国金证券",
                        "医疗板块",
                        "疫情应对需求",
                        "消费医疗",
                        "院内诊疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "渤海证券 - 医药行业周报：持续关注Q1业绩高增长个股【行业研究】",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "Q1业绩高增长",
                        "个股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122)首次覆盖报告：自研代理双驱 疫苗龙头未来可期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "自研代理",
                        "疫苗龙头",
                        "未来可期"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "盘前情报丨下达35亿元！海南自贸港迎来多项重磅利好，关注相关板块（附股）",
                "features": {
                    "keywords": [
                        "海南自贸港",
                        "35亿元",
                        "重磅利好",
                        "相关板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "政策受益"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}